Robert B Bazemore's Net Worth

$840 Thousand

Estimate Recalculated Feb 7, 2025 09:31PM EST

Who is Robert B Bazemore

Robert B Bazemore does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Nuvation Bio Inc., Neon Therapeutics, Inc., ARDELYX, INC., Epizyme, Inc., and SYNAGEVA BIOPHARMA CORP.

SEC CIK

Robert B Bazemore's CIK is 0001620152

Past Insider Trading and Trends

2020 was Robert B Bazemore's most active year for acquiring shares with 9 total transactions. Robert B Bazemore's most active month to acquire stocks was the month of May. 2020 was Robert B Bazemore's most active year for disposing of shares, totalling 13 transactions. Robert B Bazemore's most active month to dispose stocks was the month of May. 2020 saw Robert B Bazemore paying a total of $89,800.00 for 552,103 shares, this is the most they've acquired in one year. In 2020 Robert B Bazemore cashed out on 280,436 shares for a total of $765,340.55, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nuvation Bio Inc.

Investor
Updated Sep 05, 2024
Form 4
200.80K
Sep 05, 2024
200.80K
Grant
Sep 03
Form 4
366.74K
May 17, 2023
366.74K
Grant
May 15
Form 4/A
140.71K
Jun 28, 2022
140.71K
Grant
May 16
Form 4
118.78K
May 18, 2022
118.78K
Grant
May 16
Form 4
45.23K
Nov 02, 2021
45.23K
Grant
Oct 29
Form 4
5.00K
$9.98
$49.90K
Apr 01, 2021
5.00K
Purchase
Mar 30
Form 4
239.36K
Feb 12, 2021
239.36K
Grant
Feb 10
Form 3
Feb 12, 2021
Showing 8 results

Neon Therapeutics, Inc.

Investor
Updated May 06, 2020
Form 4
-100.00%
-46.50K
May 06, 2020
Disposition
May 06
Form 4
18.50K
Jun 27, 2019
18.50K
Grant
Jun 25
Form 4
28.00K
Nov 07, 2018
28.00K
Grant
Nov 07
Form 3
Nov 07, 2018
Showing 4 results

ARDELYX, INC.

Investor
Updated Jun 17, 2024
Form 4
40.24K
Jun 17, 2024
40.24K
Grant
Jun 14
Form 4
49.24K
Jun 16, 2023
49.24K
Grant
Jun 15
Form 4
100.00K
Jun 17, 2022
100.00K
Grant
Jun 15
Form 4
32.77K
Jun 21, 2021
32.77K
Grant
Jun 16
Form 4
23.50K
Jun 11, 2020
23.50K
Grant
Jun 09
Form 4
50.00K
Jun 17, 2019
50.00K
Grant
Jun 13
Form 4
15.00K
Jun 15, 2018
15.00K
Grant
Jun 13
Form 4
15.00K
Jun 09, 2017
15.00K
Grant
Jun 07
Form 4
25.00K
Jun 06, 2016
25.00K
Grant
Jun 02
Form 3
Jun 06, 2016
Showing 10 results

Epizyme, Inc.

President & CEO
Updated Mar 29, 2021
Form 4
-3.10%
-10.33K
$7.85
-$81.07K
Mar 29, 2021
322.63K
Sale
ScheduledMar 25
Form 4
-1.16%
-3.89K
$11.21
-$43.61K
Feb 05, 2021
331.98K
Sale
ScheduledFeb 04
Form 4
203.31%
504.94K
Feb 02, 2021
753.31K
Grant
Feb 01
Form 4
-2.39%
-6.07K
$11.41
-$69.25K
Jan 27, 2021
248.37K
Sale
ScheduledJan 25
Form 4
2.34%
5.73K
$16.15
-$77.08K
Jun 30, 2020
250.10K
Grant
ScheduledJun 25 - Jun 26
Form 4
-3.40%
-20.00K
$15.49
-$350.20K
Jun 22, 2020
567.70K
Sale
ScheduledJun 18
Form 4
0.27%
3.71K
$15.28
-$50.19K
Mar 26, 2020
1.37M
Acquisition
ScheduledMar 24 - Mar 25
Form 4
360.88%
305.55K
Feb 05, 2020
390.22K
Grant
Feb 03
Form 4
-0.38%
-326.00
$21.82
-$198.06K
Jan 27, 2020
84.67K
Sale
ScheduledJan 23 - Jan 27
Form 4
6.15%
4.93K
$12.10
-$25.10K
Jun 14, 2019
84.99K
Grant
ScheduledJun 12 - Jun 13
Form 4
9,025.55%
422.85K
Jan 28, 2019
427.53K
Grant
Jan 24
Form 4
265.86K
Feb 13, 2018
265.86K
Grant
Feb 09
Form 4
125.40%
1.71K
$6.21
$10.61K
Mar 02, 2017
3.07K
Grant
Feb 28
Form 4
335.70K
Feb 09, 2017
335.70K
Grant
Feb 08
Form 4
1.36K
$6.21
$8.46K
Sep 01, 2016
1.36K
Grant
Aug 31
Form 4
412.50K
Feb 10, 2016
412.50K
Grant
Feb 08
Form 3
Sep 14, 2015
Showing 17 results

SYNAGEVA BIOPHARMA CORP

Chief Operating Officer
Updated Jun 23, 2015
Form 4
-100.00%
-85.00K
Jun 23, 2015
Disposition
Jun 22
Form 4
16.67%
5.00K
Jun 09, 2015
35.00K
Grant
Jun 05
Form 4
80.00K
Sep 25, 2014
80.00K
Grant
Sep 23
Form 3
Sep 23, 2014
Showing 4 results

Akari Therapeutics Plc

Investor
Updated Sep 18, 2024
Form 4
5.00M
Sep 18, 2024
5.00M
Grant
Sep 17
Form 3
Sep 18, 2024
Showing 2 results